Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON32761Recruiting
Open-label trial of amoxicillin in bacterial disease, sponsored by Canisius-Wilhelmina Hospital. Primary endpoints: Amoxicillin half-life during elimination phase, Volume of distribution at steady state and 7 more. Started Dec 2010; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON32761.